NicholasMcAndrewMDMSCE
Oncology • Beverly Hills, CABreast Cancer
Assistant Professor, Division of Hematology/Oncology, University of California Los Angeles
Dr. McAndrew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
120 S. Spalding Drive, Suite 401
Beverly Hills, CA 90212Phone+1 310-205-0771Fax+1 310-205-0771- Is this information wrong?
Education & Training
Perelman School of Medicine at the University of PennsylvaniaMSCE, Clinical Epidemiology, 2016 - 2018
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2015 - 2018- University of Pennsylvania Health SystemResidency, Internal Medicine, 2012 - 2015
Perelman School of Medicine at the University of PennsylvaniaClass of 2012, MD- Villanova UniversityBS, Biology, Manga Cum Laude, 2004 - 2008
Certifications & Licensure
CA State Medical License 2018 - 2025
PA State Medical License 2012 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- Rectal Cancer Survival for Residual Carcinoma In Situ Vs. Pathologic Complete Response After Neoadjuvant Therapy.Nathan M Kohrman, Li Ding, Jordan R Wlodarczyk, Nicholas P McAndrew, Sandra D Algaze, Kyle G Cologne, Sang W Lee, Sarah E Koller> ;Diseases of the Colon and Rectum. 2024 Mar 18
- 3 citationsPreclinical and clinical activity of DZD1516, a full blood-brain barrier-penetrant, highly selective HER2 inhibitor.Jian Zhang, Nicholas P McAndrew, Xiaojia Wang, Yiqun Du, Brian DiCarlo, Mei Wang, Kan Chen, Wenlei Yu, Xichun Hu> ;Breast Cancer Research. 2023 Jul 6
- 2 citationsRuxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.Igor Makhlin, Nicholas P McAndrew, E Paul Wileyto, Amy S Clark, Robin Holmes, Lisa N Bottalico, Clementina Mesaros, Ian A Blair, Grace R Jeschke, Kevin R Fox, Susan M ...> ;NPJ Breast Cancer. 2022 Nov 11
- Join now to see all
Abstracts/Posters
- Neutropenia and response to single agent palbociclib.Nicholas Patrick McAndrew, Mark Andrew Dickson, Amy Sanders Clark, Andrea Troxel, Christopher Colameco, Maryann Gallagher, Kristi Gramlich, Kelly Zafman, David J. Vaug..., 2018 Annual ASCO Meeting, Chicago, IL, 6/2/2018
- Abstract P4-22-14: Single agent palbociclib with or without trastuzumab for the treatment of Rb+ advanced breast cancerAS Clark, X Wang, A Troxel, J Burrell, M Feldman, P Lal, P Zhang, M Rosen, M Gallagher, J Ndicu, I Nivar, J Matro, SM Domchek, KR Fox, P O'Dwyer and A DeMichele, 2016 San Antonio Breast Cancer Symposium, San Antonio, TX, 12/9/2016
- Oncotype DX scores in BRCA1 and BRCA2 associated breast cancer.Nicholas Patrick McAndrew , Kara Noelle Maxwell , Jill Stopfer , Jacquelyn Powers , Amanda C. Brandt , Jessica M. Long , Katherine L. Nathanson , Susan M. Domchek, 2015 Annual ASCO Meeting, Chicago, IL, 5/30/2015
Authored Content
- CDK4/6 Inhibitors Explored in Adjuvant Breast Cancer SettingJanuary 2019
Press Mentions
Targeted Therapy for Early Breast Cancer and Advances in PSMA PET Scans at ASCOMay 22nd, 2023
Professional Memberships
- Member
Hospital Affiliations
Ronald Reagan UCLA Medical CenterLos Angeles, California
External Links
- UCLA Health Profilehttps://www.uclahealth.org/nicholas-mcandrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
